Published Data Registry

show all
TitleAuthorsJournalPublication year
DOI
PMID
Progression characteristics of the European Friedreich's Ataxia Consortium for Translational Studies (EFACTS): a 4-year cohort study.(Open Access) Reetz K, Dogan I, (...), Schulz JBThe Lancet. Neurology2021
The case for low-level BACE1 inhibition for the prevention of Alzheimer disease.(Open Access) McDade E, Voytyuk I, (...), Lichtenthaler SFNature reviews. Neurology2021
Sulthiame impairs mitochondrial function in vitro and may trigger onset of visual loss in Leber hereditary optic neuropathy.(Open Access) Reinert MC, Pacheu-Grau D, (...), Brockmann KOrphanet journal of rare diseases2021
Plasma Neurofilament Light for Prediction of Disease Progression in Familial Frontotemporal Lobar Degeneration.(Open Access) Rojas JC, Wang P, (...), Boxer ALNeurology2021
Repositioning T(H) cell polarization from single cytokines to complex help.(Open Access) Tuzlak S, Dejean AS, (...), Becher BNature immunology2021
Post-injury immunosuppression and secondary infections are caused by an AIM2 inflammasome-driven signaling cascade.(Open Access) Roth S, Cao J, (...), Liesz AImmunity2021
The Clinical and Neuropathological Features of Sporadic (Late-Onset) and Genetic Forms of Alzheimer's Disease.(Open Access) Rujeedawa T, Carrillo Félez E, (...), Zaman SHJournal of clinical medicine2021
ADAM10-Mediated Ectodomain Shedding Is an Essential Driver of Podocyte Damage.(Open Access) Sachs M, Wetzel S, (...), Meyer-Schwesinger CJournal of the American Society of Nephrology : JASN2021
White matter aging drives microglial diversity.(Open Access) Safaiyan S, Besson-Girard S, (...), Simons MNeuron2021
Approved drugs ezetimibe and disulfiram enhance mitochondrial Ca(2+) uptake and suppress cardiac arrhythmogenesis.(Open Access) Sander P, Feng M, (...), Schredelseker JBritish journal of pharmacology2021